Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications association host pharmacodynamic effects virologic response pegylated interferon alfa
Assigning Treatment Strategy Using Real-World Data A Challenge of Real World Data: How to Assign Individuals to a Treatment Strategy When Their Data Are Consistent With Several Treatment Strategies at Baseline Garcia-Albeniz X , Hsu J, Hernan MA …
Methods for Avoidance of Selection Bias A Word of Caution: All-Cause Mortality and Residual Confounding in Medicare Claims Data Garcia-Albeniz X , Hsu J, Hernan MA. Transcript: This is a cautionary tale about the use of administrative databases for …
Identifying Psychosis in Patients with Dementia: Not a Hallucination or Delusion, the Challenge Really Exists Share on: August 22, 2019 Identifying Psychosis in Patients with Dementia: Not a Hallucination or Delusion, the Challenge Really Exists Joan …
… patients with HR+/HER2– metastatic breast cancer. Links to publications: Goyal RK, Chen H, Abughosh SM, Holmes HM, …
Benefit-Risk Assessment Do your product’s benefits outweigh its potential risks? More importantly, do you have the right data to credibly demonstrate this to regulators, payers, physicians, and patients? You can rely on our experienced team to help you …
Knowledgebase - ICER Evaluations Image Image Image Knowledgebase KB Image Image KB …
Coding Variations Hinder Vaccine Efficacy and Safety Research Variation in Rotavirus Vaccination Coding in US State Medicaid Data Layton JB , Butler AM, Brookhart MA, Panozzo CA Transcript: Valid real-world evidence depends on being able to accurately …
… 6 - Wednesday, February 7, 2024 Meeting website In response to a US Congressional request, an ad hoc committee …
Benefit-Risk Preferences Benefit-risk preference studies are a specific application of stated-preference methods and are used to determine how your patients and other decision-makers perceive the benefits of your treatment features and their tolerance for …
Submission Requirements of Nordic HTA Organizations for Medical Technologies Maria Kinderås, MSc Senior Associate, Market Access and Outcomes Strategy Transcript: While health technology assessments, or HTAs, of pharmaceutical products have existed for a …